Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Feedback Regulation of Calcium Concentration01:27

Feedback Regulation of Calcium Concentration

3.9K
Calcium is an essential signaling molecule required for various cellular functions. Calcium pumps and ion channels on cell and organellar membranes, such as those on the endoplasmic reticulum (ER), regulate calcium concentrations inside the cell. They remain closed, keeping the cytosolic calcium levels low at a resting state.
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...
3.9K
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

1.2K
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
1.2K
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

1.4K
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
1.4K
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

1.6K
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
1.6K
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

1.6K
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
1.6K
Ion Channels01:19

Ion Channels

91.2K
The movement of ions like sodium, potassium, and calcium into and out of the cell is essential to maintain the electrochemical gradient in living cells. The ion channels—a class of membrane transport proteins—help maintain this ionic gradient for the smooth functioning of physiological activities such as maintaining cell size and volume, conducting nerve impulses, and gas and nutrient exchange.
Ion channels are specialized integral membrane proteins on the plasma membrane that allow...
91.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Probing Scalar-Neutrino and Scalar-Dark-Matter Interactions with PandaX-4T.

Physical review letters·2026
Same author

Comparative efficacy of botulinum toxin and surgical treatment for acute acquired concomitant esotropia: a systematic review and meta-analysis.

Frontiers in pharmacology·2026
Same author

Emerging Pharmacological Strategies for Trigeminal Neuralgia.

CNS drugs·2026
Same author

Material-Encoded Synchronization of Immunogenic Cell Death With Adenosine A2A Receptor Blockade Reprograms the Tumor Microenvironment.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Targeted Therapy and Oral Chemotherapy as Maintenance Treatment in Pediatric Very-High-Risk and High-Risk Rhabdomyosarcoma: A Retrospective Study of Efficacy and Safety.

International journal of cancer·2026
Same author

Umbilical cord blood natural killer cells improve anti-GD2 antibody efficacy in neuroblastoma: from mouse to human.

Oncoimmunology·2026

Related Experiment Video

Updated: Jan 20, 2026

Single-Cell Calcium Imaging for Studying the Activation of Calcium Ion Channels
07:17

Single-Cell Calcium Imaging for Studying the Activation of Calcium Ion Channels

Published on: December 13, 2024

1.8K

SUMOylation regulates USP5-Cav3.2 calcium channel interactions.

Agustin Garcia-Caballero1, Fang-Xiong Zhang1, Lina Chen1

  • 1Department of Physiology and Pharmacology, Alberta Children's Hospital Research Institute, Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, T2N 4N1, Canada.

Molecular Brain
|August 29, 2019
PubMed
Summary

SUMOylation of USP5 regulates its interaction with Cav3.2 calcium channels, impacting pain signaling. Reduced USP5 SUMOylation after nerve injury may alter Cav3.2 channel activity in neuropathic pain.

Keywords:
Calcium channelCav3.2PainSUMOylationT-typeUSP5Ubiquitination

More Related Videos

In Vivo Detection and Analysis of Rb Protein SUMOylation in Human Cells
09:40

In Vivo Detection and Analysis of Rb Protein SUMOylation in Human Cells

Published on: November 2, 2017

7.7K
Single-channel Analysis and Calcium Imaging in the Podocytes of the Freshly Isolated Glomeruli
12:19

Single-channel Analysis and Calcium Imaging in the Podocytes of the Freshly Isolated Glomeruli

Published on: June 27, 2015

11.6K

Related Experiment Videos

Last Updated: Jan 20, 2026

Single-Cell Calcium Imaging for Studying the Activation of Calcium Ion Channels
07:17

Single-Cell Calcium Imaging for Studying the Activation of Calcium Ion Channels

Published on: December 13, 2024

1.8K
In Vivo Detection and Analysis of Rb Protein SUMOylation in Human Cells
09:40

In Vivo Detection and Analysis of Rb Protein SUMOylation in Human Cells

Published on: November 2, 2017

7.7K
Single-channel Analysis and Calcium Imaging in the Podocytes of the Freshly Isolated Glomeruli
12:19

Single-channel Analysis and Calcium Imaging in the Podocytes of the Freshly Isolated Glomeruli

Published on: June 27, 2015

11.6K

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pain Research

Background:

  • Cav3.2 calcium channels are crucial for pain signal transmission in the primary afferent pathway.
  • The deubiquitinase USP5 regulates Cav3.2 channels and peripheral pain signal transmission.
  • Understanding the regulation of Cav3.2-USP5 interaction is vital for pain research.

Purpose of the Study:

  • To investigate the role of SUMOylation in regulating the interaction between Cav3.2 calcium channels and USP5.
  • To determine how peripheral nerve injury affects USP5 SUMOylation and its subsequent impact on Cav3.2 channel activity.

Main Methods:

  • Analysis of endogenous USP5 SUMOylation in dorsal root ganglia.
  • SUMO prediction software to identify potential SUMOylation sites on USP5.
  • Site-directed mutagenesis (USP5-K113R) and expression in tsA-201 cells.
  • Immunoprecipitation assays to assess Cav3.2-USP5 interaction.

Main Results:

  • Endogenous USP5 undergoes SUMOylation, which is decreased after peripheral nerve injury.
  • Lysine 113 (K113) was identified as a key site for USP5 SUMO2/3 modification.
  • The USP5-K113R mutant showed increased binding affinity to Cav3.2 compared to wild-type USP5.
  • SUMO2/3 modification of USP5 reduces its interaction with the Cav3.2 calcium channel.

Conclusions:

  • USP5 SUMOylation is a critical regulator of its interaction with Cav3.2 calcium channels.
  • Dysregulated USP5 SUMOylation following peripheral nerve injury may contribute to altered Cav3.2 channel function in neuropathic pain.
  • This study reveals a novel regulatory mechanism for Cav3.2 channels in the context of pain.